Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
Company advances manufacturing scale-up, regulatory testing and preclinical work supporting its planned FDA 510(k) submission in the first quarter of 2027. Multiple scaled-up batches of CXU™ material met predefined specifications, supporting both …